Our experiments revealed that on the one hand, Endocan affects the phenotype of GBM cells, and on the other hand, by direct and indirect mechanisms further promotes microvascular proliferation within the tumor (Fig. 8). The gene discussed is ESM1; the disease is glioblastoma.